000 01657 a2200469 4500
005 20250515021850.0
264 0 _c20060606
008 200606s 0 0 eng d
022 _a0165-2427
024 7 _a10.1016/j.vetimm.2006.01.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMinke, J M
245 0 0 _aUse of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
_h[electronic resource]
260 _bVeterinary immunology and immunopathology
_cMay 2006
300 _a47-57 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial
650 0 4 _aAdjuvants, Immunologic
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAntibodies, Viral
_xblood
650 0 4 _aFemale
650 0 4 _aHerpesviridae Infections
_ximmunology
650 0 4 _aHerpesvirus 1, Equid
_xgenetics
650 0 4 _aHerpesvirus Vaccines
_xgenetics
650 0 4 _aHorse Diseases
_ximmunology
650 0 4 _aHorses
650 0 4 _aMale
650 0 4 _aNeutralization Tests
_xveterinary
650 0 4 _aPolymerase Chain Reaction
_xveterinary
650 0 4 _aStatistics, Nonparametric
650 0 4 _aVaccination
_xmethods
650 0 4 _aVaccines, DNA
_ximmunology
650 0 4 _aViral Envelope Proteins
_xgenetics
650 0 4 _aViral Vaccines
_xgenetics
700 1 _aFischer, L
700 1 _aBaudu, Ph
700 1 _aGuigal, P M
700 1 _aSindle, T
700 1 _aMumford, J A
700 1 _aAudonnet, J C
773 0 _tVeterinary immunology and immunopathology
_gvol. 111
_gno. 1-2
_gp. 47-57
856 4 0 _uhttps://doi.org/10.1016/j.vetimm.2006.01.008
_zAvailable from publisher's website
999 _c16186726
_d16186726